Yirendai IPO Fizzles
Yirendai priced its IPO at $10 per American depositary share, the midpoint of the expected range. But by the noon hour Friday, shares had dropped more than 12%.
Yirendai priced its IPO at $10 per American depositary share, the midpoint of the expected range. But by the noon hour Friday, shares had dropped more than 12%.
24/7 Wall St. has been reviewing sectors backward and forward and wanted to look at the conglomerates for an outlook in 2016.
The SEC has announced that two JPMorgan wealth management subsidiaries have agreed to pay $267 million and admit wrongdoing to settle charges regarding a failure to disclose conflicts of interest to clients.
So far in December, three companies in the energy sector have combined to add $1.8 billion in default volume to the year-to-date total in institutional leveraged loan defaults.
Volkswagen has hired Kenneth Feinberg to create a compensation program for U.S. owners of more than 500,000 VW diesel-powered cars with software enabling the cars to lower carbon emissions when being tested.
SecureWorks has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Most investors in Qihoo 360 Technology woke up Friday morning to an announcement that the company is being acquired by a consortium of investors.
ReachLocal raised its outlook for fourth-quarter 2015 adjusted EBITDA and announced a series of strategic actions to improve adjusted EBITDA and its liquidity position in order to provide a foundation for future growth.
CarMax reported disappointing fiscal third-quarter financial results before the markets opened on Friday.
Moody's Investors Service says that Disney's release of "Star Wars: The Force Awakens" is credit positive. That may not be a credit rating upgrade, but it is unusual.
These stocks are perfect for more conservative growth investors. They all pay solid dividend and offer solid upside from current trading levels.
Despite having a dismal year, Micron Technology might be turning things around with its most recent acquisition.
Microsoft has been upgraded by Goldman Sachs to Neutral from Sell, which removes the stock from the firm's Americas Sell List.
In what still may be a pricey market, these stock make good sense for growth accounts looking to add value, and they are far safer than high-volatility momentum stocks.
Intercept Pharmaceuticals announced that the FDA has extended the PDUFA date for its Priority Review of obeticholic acid in primary biliary cholangitis.